WLLW Stock Overview
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Willow Biosciences Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.10 |
52 Week High | CA$0.17 |
52 Week Low | CA$0.06 |
Beta | 1.11 |
1 Month Change | -20.00% |
3 Month Change | 0% |
1 Year Change | 17.65% |
3 Year Change | -92.59% |
5 Year Change | n/a |
Change since IPO | -96.67% |
Recent News & Updates
Recent updates
Is Willow Biosciences (TSE:WLLW) In A Good Position To Deliver On Growth Plans?
Apr 11We Think Willow Biosciences (TSE:WLLW) Needs To Drive Business Growth Carefully
Dec 20We Think Willow Biosciences (TSE:WLLW) Can Afford To Drive Business Growth
Sep 02We Think Willow Biosciences (TSE:WLLW) Can Easily Afford To Drive Business Growth
May 20Calculating The Fair Value Of Willow Biosciences Inc. (TSE:WLLW)
Jan 19Shareholder Returns
WLLW | CA Biotechs | CA Market | |
---|---|---|---|
7D | 0% | -1.8% | 0.2% |
1Y | 17.6% | -28.6% | 9.0% |
Return vs Industry: WLLW exceeded the Canadian Biotechs industry which returned -27.7% over the past year.
Return vs Market: WLLW exceeded the Canadian Market which returned 9.3% over the past year.
Price Volatility
WLLW volatility | |
---|---|
WLLW Average Weekly Movement | 12.5% |
Biotechs Industry Average Movement | 13.5% |
Market Average Movement | 8.6% |
10% most volatile stocks in CA Market | 18.5% |
10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: WLLW's share price has been volatile over the past 3 months.
Volatility Over Time: WLLW's weekly volatility (13%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 32 | Chris Savile | https://www.willowbio.com |
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation. Willow Biosciences Inc. is headquartered in Calgary, Canada.
Willow Biosciences Inc. Fundamentals Summary
WLLW fundamental statistics | |
---|---|
Market cap | CA$12.06m |
Earnings (TTM) | -CA$15.31m |
Revenue (TTM) | CA$1.59m |
8.0x
P/S Ratio-0.8x
P/E RatioIs WLLW overvalued?
See Fair Value and valuation analysisEarnings & Revenue
WLLW income statement (TTM) | |
---|---|
Revenue | CA$1.59m |
Cost of Revenue | CA$7.76m |
Gross Profit | -CA$6.17m |
Other Expenses | CA$9.14m |
Earnings | -CA$15.31m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.12 |
Gross Margin | -387.32% |
Net Profit Margin | -961.27% |
Debt/Equity Ratio | 5.2% |
How did WLLW perform over the long term?
See historical performance and comparison